The Role of Universal Cancer Only Marker SIX6 in Diagnosing Non-Muscle Invasive Bladder Cancer

NCT07252297 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

177

Enrollment

OTHER

Sponsor class

Conditions

Non-muscle Invasive Bladder Cancer

Interventions

DIAGNOSTIC_TEST: SIX6 Gene Methylation Assay

Sponsor

Xijing Hospital